Epilepsia Open (Mar 2021)

Impact of the COVID‐19 lockdown on patients and families with Dravet syndrome

  • Isabella Brambilla,
  • José Ángel Aibar,
  • Anne Sophie Hallet,
  • Irena Bibic,
  • Elena Cardenal‐Muñoz,
  • Igor Prpic,
  • Francesca Darra,
  • Nicola Specchio,
  • Rima Nabbout

DOI
https://doi.org/10.1002/epi4.12464
Journal volume & issue
Vol. 6, no. 1
pp. 216 – 224

Abstract

Read online

Abstract We explored the impact of coronavirus virus 2019 (COVID‐19) pandemic on patients with Dravet syndrome (DS) and their family. With European patient advocacy groups (PAGs), we developed an online survey in 10 languages to question health status, behavior, personal protection, and health services before and after lockdown. Approximately 538 European PAG members received electronic invitations. Survey ran from April 14, to May 17, 2020, with 219 answers; median age 9 year 10 months. Protection against infection was highly used prior to COVID‐19, but 88% added facemask‐use according to pandemic recommendations. Only one patient was tested positive for COVID‐19. Most had stable epilepsy during lockdown, and few families (4%) needed emergency care during lockdown. However, behavior disorder worsened in over one‐third of patients, regardless of epilepsy changes. Half of appointments scheduled prior to lockdown were postponed; 12 patients (11%) had appointments fulfilled; and 39 (36%) had remote consultations. Responders welcomed remote consultations. Half of responders were unsatisfied with psychological remote support as only few (21 families) received this support. None of the five of patient in clinical trials stopped investigational treatment. Prior adoption of protective measures against general infection might have contributed to avoiding COVID‐19 infections. Protocols for the favored remote contact ought to now be prepared.

Keywords